
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition
Keywords: RTK inhibitor; Pertuzumab; PI3K/PTEN/AKT signalling network; Anticancer drug resistance; Sensitivity analysis; Drug combination